As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, including Walgreens (NASDAQ:WBA) and its peers.
Walgreens has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 22.7% and now trades at $11.12. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Shares of data-mining and analytics company Palantir (NYSE:PLTR)
fell 6.1% in the morning session after Jefferies analysts reiterated a Sell rating, raising concerns about the stock's valuation. The analysts added, "This positive momentum is baked into PLTR's valuation at 45x CY26E, the most expensive stock in our coverage. Fundamentals have been strong, but valuation remains the biggest concern, and insiders continue to sell, with co-founder Stephen Cohen selling another $310M in shares over the past few days."
Stefano Pessina will nearly double his Walgreens stake to 30% in Sycamore's $23.7 billion buyout, positioning himself for a key role as the company faces potential restructuring.
March 16, 2025 – 1:54 PM PDT
The Dow Jones Industrial Average has experienced significant turbulence in recent weeks, driven by economic uncertainty, shifting trade policies, and mixed corporate performances. As of mid-March 2025, the index has hovered near correction territory, down 9.3% from its December peak, reflecting broader
Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunities
FDA tested 95 benzoyl peroxide acne products for benzene, finding six with elevated levels. Affected brands issued retail-level recalls with no consumer action needed.
Shares of data-mining and analytics company Palantir (NYSE:PLTR)
jumped 7% in the pre-market session after the company revealed new commercial customers, including Walgreens Boots Alliance and Heineken. This signals that Palantir's commercial business is gaining traction beyond its traditional government contracts. Signing up major names like Walgreens Boots Alliance and Heineken highlights a shift that could help diversify its revenue streams.
Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.
Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) jumped 7.4% in the morning session after the company agreed to be acquired by Sycamore Partners for $10 billion. The acquisition price represents a roughly 8% premium to the stock's trading price a day before the news was public.
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
